Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subject: LIC

CANImmunize Partners With Medimap to Improve Healthcare Access for Canadians


This innovative partnership is a key step forward to removing barriers, increasing access, and simplifying the patient journey.

OTTAWA, ON and VANCOUVER, BC, Jan. 31, 2024 /CNW/ - CANImmunize is excited to announce a new strategic partnership with Medimap, a free web platform for Canadians to locate and access care across a variety of healthcare specialties. Medimap is a marketplace that matches patients and healthcare providers, enabling patients to locate care providers, search for the most convenient appointment available to them, and compare providers and view wait times for care in their area.

It is estimated that one-in-five Canadians do not have a family doctor, while three-in-ten say it is difficult to get an appointment with their GP. Access to regular care is essential to promoting better health outcomes, and reducing visits to our resource strained emergency departments and hospitals.

Medimap and CANImmunize have a shared vision of improving patient access to healthcare services. By combining our shared expertise in helping Canadians access credible, high-quality healthcare resources, we will reduce the current barriers that patients face when trying to access care. Our teams and technologies aim to work together to uncover opportunities to optimize centralized, simplified, and seamless healthcare booking, education, and patient navigation experiences. Our goal is to provide governments and public health authorities across Canada with swift, versatile, and data-driven solutions and technologies that enable positive healthcare outcomes.

"CANImmunize and Medimap work towards the same goal of helping Canadians achieve better health outcomes by helping them navigate the system more efficiently, so this is a win-win for everyone" said Medimap CEO, Thomas Jankowski.

About CANImmunize

CANImmunize is a Canadian digital health company that is working to build the technological future our public health systems deserve. CANImmunize specializes in building modern and accessible digital health solutions for governments, public health units, businesses, and Canadians. Our flagship product, ClinicFlow, was developed to support immunization campaigns of any size and powers COVID-19, Influenza, school-age, and routine immunization campaigns in four provinces and territories. ClinicFlow has been heralded as Canada's best COVID-19 immunization system by two independent reviews. For more information, please visit canimmunize.ca

About Medimap

Medimap's platform is used by a network of more than 4,200 practices, pharmacies and walk-in clinics across the country and has helped more than 12 million Canadians find the care they need, when they need it. Medimap's platform also provides patients the ability to book appointments with allied health professionals such as physiotherapists, chiropractors, optometrists, mental health services and more. Not only does this help patients receive timely care, it also helps the healthcare system divert people away from emergency rooms to primary care services that are better suited for their needs, including virtual appointments.  For more information, please visit medimap.ca

SOURCE CANImmunize


These press releases may also interest you

30 jun 2024
NOVOSENSE Microelectronics, a global automotive chip provider, recently announced the launch of its latest product collection, delivering high-quality solutions tailored for automotive lighting, powertrain, BMS, thermal management systems. Advanced...

30 jun 2024
KKR, a leading global investment firm, and Teachers' Venture Growth (TVG), the late-stage venture and growth investment arm of Ontario Teachers' Pension Plan, today announced the signing of definitive agreements under which KKR (on behalf of funds...

30 jun 2024
At a recent event in Shanghai, Squirrel Ai unveiled its latest achievement: a multimodal Large Adaptive Model (LAM) that represents a major step forward in educational technology. The conference revealed significant upgrades to both the model and the...

30 jun 2024
Pomelo Group is proud to announce the endorsement of...

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...

30 jun 2024
"AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry." At the 15th Annual Meeting of the New...



News published on and distributed by: